KSHG005

KSHG005 is a generic peptide drug candidate being developed by Kashiv BioSciences (formerly Kasway Biotech) for the treatment of fertility-related conditions. Currently in Phase 1 clinical development, KSHG005 is designed as a generic version of an existing peptide medication, likely a gonadotropin-releasing hormone (GnRH) receptor modulator. Such peptides are commonly used in assisted reproductive technology (ART) to prevent premature ovulation by regulating the release of luteinizing hormone and follicle-stimulating hormone. As a generic peptide, KSHG005 is intended to be bioequivalent to a reference listed drug, providing a more accessible therapeutic option for patients undergoing fertility treatments.